Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Methodological Research Priorities for developing PPI in clinical trials.

[vc_row][vc_column][vc_column_text css=”.vc_custom_1520857264156{margin-bottom: 0px !important;}”]METHODICAL

A recent priority setting exercise, the METHODICAL study, has identified sixteen critically important research topics to improve Patient and Public Involvement (PPI) within Clinical trials.

PPI in Clinical trials is seen as increasing important and many UK funders now require researchers to provide evidence of how it has and will inform their studies. Traditionally PPI tends to involve a small number of patients or members of the public (known as PPI contributors) to offer a distinctive perspective to researchers or clinicians on the design and conduct of a trial. Some PPI contributors will have direct personal experience of the condition being investigated, whilst others bring general experience of being a patient or service users.

Despite the emphasis on PPI in the UK and internationally, there are uncertainties about how best to implement it, about the purpose of PPI and whether it actually does improve research.

We recently undertook a national priority setting exercise to determine the methodological research priorities for addressing these uncertainties. 237 people from across the UK registered to take part in an online two round Delphi survey, representing  a wide range of PPI stakeholders such as PPI contributors, funders, chief investigators, trial managers, researchers, PPI coordinators and PPI advisors.

A face to face meeting of 25 randomly chosen representatives from across the stakeholder groups was used to discuss the online survey results and decide on future research priorities. Sixteen topics were voted as critically important and should form the basis for future research.

The METHODICAL results have recently been published in the journal Health Expectations (http://onlinelibrary.wiley.com/doi/10.1111/hex.12583/full) and we are now looking to facilitate the start-up of collaborative working groups on each of these critically important topics. The aim is that these groups will generate future grant proposals in order to develop the evidence base for PPI.

If you are interested in the results of the study, or would like to register to be part of a working group please visit www.methodicalstudy.uk.[/vc_column_text][/vc_column][/vc_row]

Share:
Get the latest HRB-TMRN news

Our Network operates across five University Partners,
each leading the way in trials methodology research and training